Boston Scientific today shared new findings supporting intravascular ultrasound (IVUS)-guided percutaneous coronary ...

Haemonetics (NYSE:HAE) announced today that it received FDA approval to expand the labeling for its Vascade MVP XL system.

Vicarious Surgical announced today that it completed the initial integrated benchtop testing for its full suite of surgical ...

Abbott (NYSE:ABT) announced today that it integrated its comprehensive Precision Oncology portfolio into Flatiron's OncoEMR ...

Solventum Chief Commercial Officer Heather Knight will open DeviceTalks Minnesota on May 4, 2026 with a keynote interview.

Sight Sciences (Nasdaq:SGHT) announced today that a court preserved a verdict awarding $34 million in a patent spat with ...

Medtronic (NYSE:MDT) today announced CE mark approval and the first commercial European implants for its OmniaSecure system.

Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its Asurys fluid management system.

HistoSonics announced the first successful treatments in a study of its Edison histotripsy system for benign prostatic hyperplasia (BPH).

Edwards Lifesciences (NYSE:EW) today shared new data for its Evoque transcatheter tricuspid valve replacement (TTVR) system.

Abbott (NYSE:ABT) said a new clinical trial demonstrated the reduction in heart failure hospitalization (HFH) risk with its TriClip system.

DMedical announced today that it received CE mark approval for its CT:VQ SaaS imaging platform and raised approximately $60 million.